⌕
Medpace Holdings · MEDP · Nasdaq
Tenet 59 · Mixed
Compare
$653.09+0.75%At closeTenet 59 · Mixed
$653.09+4.89 (+0.75%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Medpace Holdings (MEDP) Stock

Medpace Holdings (MEDP) closed at $653.09 on Nov 17, 2026; its Tenet Score is 59 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

8 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$653.09
Nov 17, 2026
Market cap
$18.1B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
35.5×
TTM through Sep 30, 2026 · as of close, Nov 16, 2026
52-week range
373.00 – 693.97
low → high · as of close, Nov 16, 2026
Tenet Score
59/100
Mixed · 340 Healthcare peers

Industry: Drugs

Medpace Holdings Inc scores 59/100. Mixed. Strongest on growth and quality, value is the soft spot, trading at 36× earnings versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
59/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
33
Quality
77
Health
43
Growth
82

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityBHealthDGrowthBMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
31.0×
Sep 30, 2026 balance sheet
P/S
6.4×
price to sales, TTM through Sep 30, 2026 · as of close, Nov 16, 2026
ROE
118%
TTM through Sep 30, 2026
Operating margin
21.1%
fiscal 2025, before interest and tax
Net margin
18.2%
TTM through Sep 30, 2026
Current ratio
0.83
Sep 30, 2026 balance sheet
Net debt / EBITDA
−1.1×
TTM through Sep 30, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeuti…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 217 US ETFs · top wrappers by weightSee all ETFs holding MEDP →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Medpace Holdings in?

Medpace Holdings is in the Healthcare sector and the Drugs industry.

What is Medpace Holdings' Tenet Score?

Medpace Holdings' Tenet Score is 59 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.